The GPR87 Polyclonal Antibody (CAB15162) is designed for research involving GPR87, a G-protein coupled receptor known for its role in inflammation and cancer progression. The antibody, produced in rabbits, is highly specific to human samples and is validated for use in various applications such as Western blotting.GPR87 is a promising target for cancer therapy due to its involvement in tumor growth, invasion, and metastasis. By targeting GPR87, researchers aim to develop novel treatment strategies for various types of cancer.
Additionally, GPR87 has been implicated in inflammatory processes, suggesting its potential as a therapeutic target for inflammatory conditions.This antibody enables the specific detection and analysis of GPR87 in different cell types, making it a valuable tool for studies related to cancer biology, inflammation, and drug development. Understanding the role of GPR87 in disease pathogenesis is essential for the development of targeted therapies that could improve patient outcomes in cancer and inflammatory diseases.
Product Name:
GPR87 Rabbit Polyclonal Antibody
SKU:
CAB15162
Size:
20uL, 100uL
Isotype:
IgG
Host Species:
Rabbit
Reactivity:
Human
Immunogen:
A synthetic peptide corresponding to a sequence within amino acids 250-350 of human GPR87 (NP_076404.3).
This gene encodes a G protein-coupled receptor and is located in a cluster of G protein-couple receptor genes on chromosome 3. The encoded protein has been shown to be overexpressed in lung squamous cell carcinoma (PMID:18057535) and regulated by p53 (PMID:19602589).
Purification Method:
Affinity purification
Gene ID:
53836
Storage Buffer:
Store at -20℃. Avoid freeze / thaw cycles.Buffer: PBS with 0.01% thimerosal,50% glycerol,pH7.3.
Western blot analysis of lysates from DU145 cells, using GPR87 Rabbit pAb (CAB15162) at 1:1000 dilution.Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (CABS014) at 1:10000 dilution.Lysates/proteins: 25μg per lane.Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Basic Kit (AbGn00020).Exposure time: 90s.
